LASIK术后角膜瓣表面PRK二次治疗的临床效果观察

目的 :探讨LASIK术后屈光回退和 /或欠矫行角膜瓣表面PRK治疗的效果和并发症。方法 :LASIK术后屈光回退和 /或欠矫患者 16例 2 2眼 ,PRK术前屈光度等值球镜值 -1 5 7D± 0 46D ,平均角膜瓣下剩余基质厚度 2 47 14 μm± 19 3 5 μm ,角膜瓣表面平均PRK切削深度 2 3 5 5 μm± 8 3 1μm。PRK术前裸眼视力 0 2～ 0 5 ,最佳矫正视力均大于 1 0。结果 :术后 1个月裸眼视力均在 0 8以上 ,术后 6个月裸眼视力均大于 1 0者 17眼占 77 2 7% ,未见最佳矫正视力下降。PRK术后 10眼占 44 5 %出现角膜瓣haze ,其中 6眼占 2 7 2 7%为 2级haze ,术后 6个月时仍有 2级haze者 3眼占 13 63 %。未见 3级以上haze。结论 :LASIK术后屈光回退和 /或欠矫应用PRK方法进行二次治疗的效果尚满意。但术后角膜瓣haze发生率较高。     

激光治疗性角膜切削术治疗LASIK术后角膜上皮内生

目的 探讨激光治疗性角膜切削术(PTK)治疗LASIK术后角膜上皮内生的方法和效果,方法 LASIK术后较严重的角膜瓣下角膜上皮内生4例(4眼),进行内生的上皮刮除和PTK治疗后戴接触镜3～5天,随访10～24个月,结果 4例均治愈,随访期内无复发,视力均恢复至术前最佳矫正视力.眼部刺激症状、眩光消失.结论 LASIK术后瓣下角膜上皮内生,进行角膜瓣后面和角膜床表面的角膜上皮刮除及PTK术,术后戴角膜接触镜,是治疗LASIK术后瓣下角膜上皮内生的有效方法.     

PRK术中应用低浓度丝裂霉素治疗低中度近视

目的：评价PRK术中应用低浓度(0.02g/L)丝裂霉素(PRK+LMMC)30s治疗低、中度近视眼术后疗效。

方法：选取我院接受屈光性角膜切削术(PRK)治疗的30例57眼低、中度近视患者,术中应用0.02g/L的MMC 30s,将术后6mo的随访结果与同期接受准分子激光原位角膜磨镶术(LASIK)治疗的疗效进行比较。

结果：术后6mo,PRK+LMMC治疗组等值球镜屈光度0.210D、等值球镜屈光度在±0.50D范围内的发生率71.9%、裸眼视力≥1.0者77.2%,平均最佳矫正视力1.19±0.18; LASIK治疗组等值球镜屈光度-0.017D,等值球镜屈光度在±0.50D范围内的发生率70.1%,裸眼视力≥1.0者72.7%,平均最佳矫正视力1.16±0.19,两组比较差异均无统计学意义(P>0.05)。术后6mo,PRK+LMMC治疗组没有出现超过1级的haze,所有眼最佳矫正视力均好于术前。LASIK治疗组1眼因角膜上皮植入使最佳矫正视力较术前下降3行,其余眼最佳矫正视力均好于术前。

结论：PRK术中应用0.02g/L的MMC 30s治疗低、中度近视同LASIK具有同样的视力结果,避免了LASIK瓣的并发症,不失为一个可取的手术程序。     

PRK、LASIK术后角膜地形图的变化对视力恢复的影响

目的：探讨准分子激光角膜切削术（photorefractive keratectomy,PRK)与准分子激光原位角膜磨镶术（laser insitu keratomileusis,LASIK)前后角膜地形图的变化及其与裸眼视力的关系。方法：采用EyeSys2000型角膜地形图系统测量PRK、LASIK术前及术后10天，1、3、6、12及24个月时的角膜地形图并记录同期的视力。结果：角膜地形图显示术后切削形态随着时间延长，趋于规则，Simk的差值和等效值，PRK组和LASIK组术前与术后相比都有显著性差异，术后偏心距离均在1.00mm内，术后裸眼眼力≥0．6，结论：在低、中度近视中，LASIK术后的偏心程度较PRK的稍重，引起裸眼视力偏低。     

PRK与LASIK矫正近视性散光准确性及预测性的比较

目的：评价对比准分子激光屈光性角膜切削术（PRK）与准分子激光原位角膜磨削术（LASIK）矫治近视性散光的疗效及预测性，进一步分析两种手术在治疗中存在的问题。方法：采用LASIK及PRK，对40例近视散光患者进行了分组治疗。结果：近视球镜矫正的准确性，LASIK组高于PRK组；近视散光度数的矫正及散光轴位矫正的准确性两组无明显改变；术后6个月裸眼视力达到或超过术前最佳矫正视力眼，LASIK组大于PRK组；解膜表面规则性指数（SRI）及角膜表现非规则性指数（SAI）在手术前后的变化，LASIK及PRK组无明显差异。结论：LASIK治疗近视性散光的疗效优于PRK。     

LASIK后角膜瓣皱褶和折叠的处理

目的 探讨准分子激光原位角膜磨镶术(laser in situ keratomileusis,LASIK)后早期角膜瓣皱褶和折叠的有效处理方法.方法 对LASIK术后11例角膜瓣皱褶的原因及处理进行回顾性分析.所有的患者需经手术重新复位,在显微镜下采用去离子水冲洗角膜瓣加戴角膜接触镜24 h.术后观察角膜瓣状况、屈光变化、裸眼视力和最佳矫正视力.结果 经过处理的所有患者裸眼视力均达到或超过术前最佳矫正视力.角膜透明,未见明显皱褶,角膜瓣位置正常,无上皮植入.结论 角膜瓣皱褶和折叠是LASIK术后较严重的并发症.早期诊断和正确快速的处理是获得最佳视力的关键.用去离子水重新复位角膜瓣并佩戴角膜接触镜治疗LASIK术后早期角膜瓣皱褶和折叠是安全简单有效的方法.     

LASEK、PRK和LASIK治疗中低度近视的比较

目的对比分析准分子激光上皮下角膜磨镶术(LASEK)、碰光性角膜切削术(PRK)、激光原位角膜磨镶术(LASIK)治疗中低度近视临床疗效。方法LASEK组58例(112眼)随访3-9月,PRK、LASIK组各120眼随访1a以上,观察分析术后疼痛症状,裸眼视力及角膜混浊情况。结果术后1d出现疼痛症状:LASEK组:81眼(72.3％),PRK组120 眼(100.0％),LASIK组13眼(10.8％);术后3d裸眼视力≥0.8:LASEK组24眼(21.4％),PRK组27眼(22.5％),LASIK组113 眼(94.2％);术后3月存在角膜Haze:LASEK组31眼(27.6％)、PRK组94眼(78.3％),LASIK组0眼。结论LASEK后疼痛症状、角膜Haze明显减轻,疗效优于PRK;LASEK与LASIK相比没有角膜瓣相关并发症,早期视力恢复较慢。     

LASIK治疗近视术中并发症临床分析与处理

目的：探讨准分子激光角膜原位磨镶术（LASIK）治疗近视的安全性和有效性。方法：回顾性分析LASIK治疗581只眼近视的术中并发症。结果：术后裸眼视力与术前相比,99．3％达到或超过术前最佳矫正视力。术中并发症的发生率为不完全角膜瓣占0．52％,游离角膜瓣占0．52％,角膜瓣偏位占0．34％,角膜缘出血占7．3％。结论：LASIK治疗近视安全有效,熟练掌握手术技术和有效及时处理各种并发症是保证手术成功的关键。     

LASEK与LASIK治疗高度近视

目的:对比观察准分子激光上皮瓣下角膜磨削术(LASEK)与准分子激光原位角膜磨削术(LASIK)治疗高度近视的临床疗效。评估2种手术的安全性和有效性。方法:对行LASEK治疗的39例75只眼和同期行LASIK治疗的41例79只眼高度近视分别进行6个月以上的临床观察。结果:LASEK组术后1周至1个月达最佳矫正视力,术后3个月部分出现视力回退,术后6个月裸眼视力达术前矫正视力占95.83%,主要并发症有术后高眼压及Haze形成;LASIK组术后6个月裸眼视力达术前矫正视力占94.35%,主要并发症为屈光回退,角膜上皮内生或角膜瓣皱折等。结论:LASIK与LASEK均能安全、有效地矫正高度近视。     

准分子激光治疗性切削联合屈光性切削治疗伴有角膜混浊的近视眼

目的　了解准分子激光治疗性切削 (PTK)联合屈光性切削 (PRK)治疗伴有角膜混浊近视眼的方法及疗效。方法　激光加刮除去除角膜上皮 ,PTK切削混浊角膜 ,直径为 7 0mm。PRK作近视切削 ,直径为 6 0mm。对于角膜不平者术中用黏弹剂填平后再行上皮去除及PTK。PTK切削深度为影响视力的角膜混浊深度减去PRK及上皮切削厚度。结果　 5 4例 (79只眼 )伴有角膜混浊的近视眼治疗后随访 1年以上 ,术前平均屈光度数为 (- 6 73± 4 17)D ,平均最佳矫正视力为 0 6 3,角膜混浊原因包括感染、机械外伤、化学烧伤、热烧伤、手术后瘢痕及其他原因。术中PTK联合PRK平均切削深度为 (12 4 6 3± 5 3 31) μm。术后 5 0只眼 (6 3 3% )切削区角膜上皮下雾状混浊 (Haze)≤Ⅰ级 ,6 9只眼(89 9% )裸眼视力等于或超过术前最佳矫正视力 ,平均为 0 74。角膜表面较术前光滑 ,散光减轻。结论　PTK联合PRK是治疗伴有角膜混浊近视眼的一种安全有效的方法。     

Immediate transepithelial photorefractive keratectomy for treatment of laser in situ keratomileusis flap complications

PURPOSE: To study the role of photorefractive keratectomy (PRK) in the management of laser in situ keratomileusis (LASIK) flap complications. METHODS: A retrospective analysis was performed of seven patients (14 eyes) who had bilateral, simultaneous LASIK (single surgeon [TGA], Summit Apex Plus laser, Hansatome microkeratome in six patients [12 eyes], Automated Corneal Shaper keratome in one patient [two eyes]). One eye of each patient received PRK for a flap complication. The seven patients (four women, three men) had a mean age of 39.2 years (range, 22 to 64 yr). The uncomplicated LASIK eyes had moderate to high myopia (-2.25 to -8.75 D) and the eyes with LASIK flap complications had mild to moderate myopia (-1.50 to -5.75 D). Immediate transepithelial PRK was performed in all eyes after repositioning the defective flap. RESULTS: All seven patients had excellent visual outcome at 6 months follow-up; one patient required an enhancement (astigmatic keratotomy). Six of the seven LASIK eyes had best spectacle-corrected visual acuity of 20/20 or better and one LASIK eye had 20/25. In the transepithelial PRK eyes, six of the seven eyes had best spectacle-corrected visual acuity of 20/20 or better and one eye had 20/30. CONCLUSIONS: Immediate transepithelial PRK treatment of irregular and incomplete LASIK flaps at the time of surgery is an excellent therapeutic option to delayed surgical treatment.     

Comparison of laser in situ keratomileusis and photorefractive keratectomy for the correction of myopia of -6.00 diopters or less. Melbourne Excimer Laser Group

PURPOSE: To evaluate the safety and efficacy of laser in situ keratomileusis (LASIK) compared to photorefractive keratectomy (PRK) for the correction of low or moderate myopia (-0.50 to -6.00 D) at 6 months after surgery. METHODS: The study population comprised a non-randomized consecutive series of 622 eyes of 392 patients who were treated with the Nidek EC-5000 excimer laser. LASIK was performed using the ACS Chiron microkeratome on 314 eyes and surface PRK on 308 eyes. All patients were treated using a standard protocol, then assessed at 1, 3, and 6 months postoperatively. RESULTS: Forty-four percent of the LASIK group and 67% of the PRK group attended their 6-month examination. Eighty percent of patients (111 eyes) after LASIK and 65% (136 eyes) after PRK had an uncorrected visual acuity of 20/20 or better. Spherical equivalent refraction was within +/-0.50 D of intended refraction in 78% (109 eyes) for LASIK and 82% (170 eyes) for PRK. Loss of two more lines of best spectacle-corrected visual acuity at 6 months occurred in 1.4% (2 eyes) of the LASIK group and 1.0% (2 eyes) of the PRK group. CONCLUSION: At 1 month follow-up, the percentage of eyes that achieved 20/20 uncorrected visual acuity was greater in the LASIK group than in the PRK group. At 6 months, visual and refractive outcomes of LASIK and PRK were similar. Although flap related complications occurred only after LASIK, the overall risk of loss of best spectacle-corrected visual acuity was not significantly greater than for PRK.     

Transepithelial phototherapeutic keratectomy/photorefractive keratectomy with adjunctive mitomycin-C for complicated LASIK flaps

PURPOSE: To evaluate the efficacy of transepithelial phototherapeutic keratectomy/photorefractive keratectomy (PTK/PRK) with prophylactic mitomycin-C for the treatment of refractive errors and maintenance of corneal clarity following flap complications in laser in situ keratomileusis (LASIK). SETTING: Outpatient tertiary care center, Chicago, Illinois, USA. METHODS: Ten eyes of 10 patients with LASIK flap complications had transepithelial PTK/PRK for correction of ametropia. Mitomycin-C 0.02% was applied to the stroma for 2 minutes following laser ablation. Postoperative uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), refractions, and slitlamp examinations were obtained. RESULTS: Preoperatively, the mean UCVA was 20/400 (range 20/40 to counting fingers), the mean BSCVA was 20/28.5, and the spherical equivalent refractive errors ranged from +4.00 to -10.75 diopters (D). After the procedure, the mean UCVA was 20/28, the mean BSCVA was 20/21, and the spherical equivalent refractive errors ranged from +0.37 to -1.00 D. The mean follow-up ranged from 8 to 28 months. No patient experienced delayed reepithelialization, haze, or other signs of toxicity. CONCLUSION: Mitomycin-C can be a useful adjunctive therapy for the prevention of haze when applying surface excimer laser therapy to a cornea following LASIK flap complications.     

Photorefractive keratectomy for treatment of flap complications in laser in situ keratomileusis

PURPOSE: To present the results of photorefractive keratectomy (PRK) for treatment of laser in situ keratomileusis (LASIK) flap complications. METHODS: Compilation of case reports through solicitation on Kera-net, an Internet surgery discussion site. RESULTS: PRK was performed on 13 patients from 2 weeks to 6 months after LASIK flap complications. The technique used for the PRK varied. Epithelial removal was performed using no-touch phototherapeutic keratectomy (PTK) in six of the 13 patients and manual debridement in the other seven patients. A dilute solution of 20% ethanol was used to facilitate manual debridement in five of the seven patients. In two of these five patients, the epithelium was replaced as in laser-assisted subepithelial keratomileusis (LASEK). A solution of 0.02% mitomycin C was used after laser ablation to prevent haze formation in three patients. After an average 7 months of follow-up, uncorrected visual acuity was 20/20 in six patients, 20/25 in four patients, and 20/30 in two patients. The visual acuity in one patient was 20/80, purposely left undercorrected for monovision. Best spectacle-corrected visual acuity was 20/20 in 10 of 13 patients. Three patients were 20/25, losing one line of best spectacle-corrected visual acuity. On slit-lamp examination, at last follow-up appointment, stromal haze was graded from trace to none in all patients. CONCLUSIONS: Photorefractive keratectomy is a safe and effective technique for treatment of patients with LASIK flap complications.     

Laser in situ keratomileusis for residual myopia after radial keratotomy and photorefractive keratectomy.

PURPOSE: To evaluate the visual outcome, stability, and complications of laser in situ keratomileusis (LASIK) for residual myopia after radial keratotomy (RK) and photorefractive keratectomy (PRK). SETTING: Dr. Agarwal's Eye Hospital, Chennai, India. METHODS: Twenty eyes that had LASIK treatment for residual myopia after RK (10 eyes) or PRK (10 eyes) were retrospectively analyzed. Laser in situ keratomileusis was performed after a mean period of 24.3 months +/- 0.75 (SD) in the RK group and 22.0 +/- 1.07 months in the PRK group. RESULTS: At the last follow-up, the mean spherical equivalent was reduced from -6.05 +/- 1.98 diopters (D) to -1.26 +/- 0.32 D (P <.05) in the RK group and from -3.38 +/- 1.30 D to -0.55 +/- 0.40 D (P <.005) in the PRK group. The mean uncorrected visual acuity improved from 20/300 (range 20/600 to 20/200) to 20/40 (range 20/60 to 20/20) (P <.05) and from 20/200 (range 20/800 to 20/80) to 20/25 (range 20/40 to 20/20) (P <.05), respectively. Two eyes in the RK group and 3 in the PRK group gained 1 line of best corrected visual acuity, and 2 eyes in the RK group lost 1 line. No sight-threatening complications such as a free flap, corneal ectasia, or a retinal complication occurred. There was no statistically significant difference in corneal haze before and after LASIK. Two eyes in the RK group required repositioning of the flap because of irregular apposition to the stromal bed. CONCLUSION: Laser in situ keratomileusis was safe, effective, and stable in the treatment of residual myopia after RK and PRK.     

Lower intraoperative flap complication rate with the Hansatome microkeratome compared to the Automated Corneal Shaper

PURPOSE: The purpose of this study was to retrospectively compare the incidence of intraoperative flap complications, such as partial flaps, donut-shaped flaps, central corneal cuts, and complete caps with the Hansatome and Automated Corneal Shaper (ACS) microkeratomes. METHODS: All laser in situ keratomileusis (LASIK) procedures performed by a single surgeon with the Hansatome or Automated Corneal Shaper in which intraocular pressure was verified with a pneumotonometer were reviewed. RESULTS: A total of 90 eyes had LASIK with the ACS microkeratome. Six of the ACS eyes (6.7%) had intraoperative flap complications (4 partial flaps, 1 donut-shaped flap, 0 central corneal cuts, 1 complete cap). Partial flaps and donut-shaped flaps were replaced without laser application and the procedure repeated 2 to 3 months later. Two of these eyes lost 2 lines and one lost 1 line of spectacle-corrected visual acuity at 6 months after repeat LASIK. The eye with the donut-shaped flap was treated with transepithelial photorefractive keratectomy (PRK) and had no change in spectacle-corrected visual acuity at 6 months after PRK. The eye with the complete cap had no change in spectacle-corrected visual acuity after laser ablation. Five hundred ninety-eight (598) eyes had LASIK with the Hansatome microkeratome. Two of the Hansatome eyes (0.3%) had a flap complication (1 partial flap and 1 donut-shaped flap). The first eye retained spectacle-corrected visual acuity at 6 months after repeat LASIK. The second eye had transepithelial PRK to eliminate the donut shaped flap with no loss of spectacle-corrected visual acuity at 6 months after surgery. The difference in flap complications between the two procedures was statistically significant (P < .01). There were no flap displacements following surgery in either group. CONCLUSION: Intraoperative flap complications are less likely to occur with the Hansatome microkeratome than with the ACS microkeratome.     

Clear lens extraction with intraocular lens followed by photorefractive keratectomy or laser in situ keratomileusis

OBJECTIVE: To study photorefractive keratectomy (PRK) or laser in situ keratomileusis (LASIK) after clear lens extraction (CLE) with intraocular lens (IOL) implantation for hyperopia or astigmatism. DESIGN: Retrospective, noncomparative interventional case series. PARTICIPANTS: Sixty-five eyes (55 subjects) had CLE with posterior chamber IOL implants for hyperopia up to 12.25 diopters (D); 31 eyes were retreated with PRK, and 34 eyes were retreated with LASIK for residual ametropias. INTERVENTION: For PRK and LASIK, the refractive surgery was performed with the slit-scanning excimer laser Nidek EC-5000, Nidek Co., Tokyo, Japan. MAIN OUTCOME MEASURES: Manifest refraction, best-spectacle and uncorrected Snellen visual acuity, haze, and halos were evaluated before surgery and at 1, 3, 6, and 12 months postoperative. RESULTS: Forty-seven eyes were evaluated at the 12-month postoperative examination: 96% of these eyes had spherical equivalents (SE) within +/-2 D of emmetropia, 79% of eyes had SE within +/-1 D of emmetropia and 51% of eyes had SE within +/-0.50 D of emmetropia. Eighty-five percent of the eyes at 12 months postoperative had uncorrected visual acuity of 20/40 or better, and 46% of eyes had uncorrected visual acuity of 20/20 or better. Eighty-seven percent of the eyes at 12 months postoperative had uncorrected visual acuity within 1 Snellen line of their initial best spectacle-corrected visual acuity (BSCVA) before all treatment. No eye lost 2 Snellen lines of BSCVA at 3, 6, or 12 months after PRK or after LASIK. CONCLUSIONS: IOL implantation for CLE, although an invasive technique, resulted in better refractive outcomes without laser-related clinical complications after PRK or LASIK adjustment.     

Laser in situ keratomileusis enhancement after photorefractive keratectomy

OBJECTIVE: To describe the safety, effectiveness, and predictability of laser in situ keratomileusis (LASIK) for correcting residual myopia after primary photorefractive keratectomy (PRK). DESIGN: A retrospective, noncomparative case series. PARTICIPANTS AND INTERVENTION: Thirty-six consecutive eyes of 30 patients underwent LASIK after primary PRK. A Multiscan Schwind excimer laser was used for LASIK enhancement. MAIN OUTCOME MEASURES: Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity, refraction, videokeratography, and complications were determined before and after LASIK retreatment. Follow-up was at least 12 months. RESULTS: Before LASIK, 11.11% of eyes showed a UCVA of 20/40 or better. This increased to 94.44% 12 months after LASIK. A UCVA of 20/25 or better was achieved in 0% before and in 72.22% after retreatment. Refraction +/-0.5 diopters (spherical equivalent) represented 0% of eyes before and 77.78% of eyes after enhancement. Before LASIK, two eyes had significant haze. Haze remained in these two eyes and appeared in another eye. CONCLUSIONS: Laser in situ keratomileusis proved to be safe and effective for treating residual myopia after PRK. Care must be taken when considering LASIK retreatment in patients with significant haze after primary PRK.     

The safety and efficacy of photorefractive keratectomy after laser in situ keratomileusis

PURPOSE: To determine the safety and efficacy of performing photorefractive keratectomy (PRK) in corneas previously treated with laser in situ keratomileusis (LASIK) surgery. METHODS: Fifteen eyes of 14 patients who had initially received LASIK for the treatment of myopia and compound myopic astigmatism were evaluated. Variables included existence of and/or type of flap complication associated with the original LASIK procedure, refractions before and after (3 and 6 months) PRK, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), and the development of complications after PRK such as haze, scarring, double vision, or ghosting. RESULTS: All 15 eyes were available for analysis at 6 months. Eleven eyes had experienced flap complications during the initial LASIK procedure and 4 eyes had experienced complications in the LASIK postoperative period. Characteristics prior to performing PRK included 11 myopic and 4 hyperopic eyes. By 6 months after PRK treatment, 87% of eyes had UCVA > or = 20/40, 53% had > or = 20/25, and 40% had > or = 20/20. All eyes had BSCVA of > or = 20/30, with 73% being > or = 20/20. No eye had lost 2 lines of BSCVA and only 1 eye lost 1 line of BSCVA. Sixty percent of eyes were within 1.0 diopters (D) of emmetropia, and 40% were within 0.5 D of emmetropia. A trend towards undercorrection and surgical induction of astigmatism as confirmed by vector analysis was noted. No eye developed significant haze or scarring. CONCLUSIONS: Photorefractive keratectomy may be a safe procedure to perform in corneas previously treated with LASIK surgery. Results show good reduction of refractive error and improvement of UCVA and BSCVA. A significant undercorrection of astigmatism was attributed to surgically induced astigmatism. Further studies are necessary to determine the long-term safety and stability of outcomes.